How everyone on Medicare could end up paying for the pricey new Alzheimer's drug
CNN
The controversial new drug for Alzheimer's disease, Aduhelm, is priced at $56,000 a year for treatment -- but Alzheimer's patients won't be the only ones shouldering the cost.
All of Medicare's roughly 60 million enrollees will likely see their premiums rise to cover the new medication, experts say -- and the burden will also fall to federal and state governments and, therefore, to taxpayers.Elected officials, Jewish advocacy groups and civil rights leaders are vowing to “push back” against the message of a White nationalist group that staged a march last week near downtown Columbus, Ohio, calling the demonstration an act of hate unwelcome in their community – and the United States more broadly.
Senate Democrats have confirmed some of President Joe Biden’s picks for the federal bench this week in the face of President-elect Donald Trump’s calls for a total GOP blockade of judicial nominations – in part because several Republicans involved with the Trump transition process have been missing votes.